Powder: -20°C for 3 years
In solvent: -80°C for 2 years
LY364947 is a potent ATP-competitive inhibitor of TGFβR-I.
Description | LY364947 is a potent ATP-competitive inhibitor of TGFβR-I. |
Targets&IC50 | TGFβRII:0.4 μM, RIPK2:0.11 μM, CK1δ:0.22 μM, TGFβRI:59 nM, MLK-7K:1.4 μM |
Kinase Assay | The IC50 of LY-364947 at different enzyme concentrations are determined by the filter-binding assay. Typically, 40 μL reactions in 50 mM HEPES at pH 7.5, 1 mM NaF, 200 μM pKSmad3(-3), and 50 mM ATP containing a titration of each inhibitor with concentrations of 1600, 800, 400, 200, 100, 50, 25, and 0 nM are incubated at 30°C for 30 min. The IC50 is calculated using a nonlinear regression method with GraphPad Prism software. The binding type is determined by plotting the correlation between enzyme concentrations and IC50 values. |
Synonyms | LY 364947, HTS466284 |
Molecular Weight | 272.3 |
Formula | C17H12N4 |
CAS No. | 396129-53-6 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 27.2 mg/mL (100 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LY-364947 396129-53-6 Apoptosis MAPK Metabolism NF-Κb Stem Cells MLK RIP kinase TGF-beta/Smad Casein Kinase LY364947 LY 364947 Transforming growth factor beta receptors Inhibitor inhibit HTS-466284 HTS 466284 HTS466284 TGF-β Receptor inhibitor